Adial Pharmaceuticals, Inc. Form DEF 14A: Definitive proxy statement
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-08-24: Form DEF 14A; Period of report 2026-09-17; Description PROXY STATEMENT; Document ea0299259-03.htm.
- 2026-01-06: Form DEF 14A; Period of report 2026-02-26; Description DEFINITIVE PROXY STATEMENT; Document ea0270782-def14a_adialpharma.htm.
- 2025-06-10: Form DEF 14A; Period of report 2025-07-24; Description PROXY STATEMENT; Document ea0243378-02.htm.
- 2024-09-27: Form DEF 14A; Period of report 2024-11-12; Description PROXY STATEMENT; Document ea0212489-01.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2026-08-24 | DEF 14A | 2026-09-17 | PROXY STATEMENT | ea0299259-03.htm |
| 2026-01-06 | DEF 14A | 2026-02-26 | DEFINITIVE PROXY STATEMENT | ea0270782-def14a_adialpharma.htm |
| 2025-06-10 | DEF 14A | 2025-07-24 | PROXY STATEMENT | ea0243378-02.htm |
| 2024-09-27 | DEF 14A | 2024-11-12 | PROXY STATEMENT | ea0212489-01.htm |
| 2023-12-08 | DEF 14A | 2024-01-11 | PROXY STATEMENT | def14a1223_adialpharma.htm |
| 2023-10-02 | DEF 14A | 2023-11-02 | PROXY STATEMENT | def14a0923_adialpharma.htm |
| 2023-03-06 | DEF 14A | 2023-04-12 | PROXY STATEMENT | def14a0323_adialpharma.htm |
| 2022-09-01 | DEF 14A | 2022-10-13 | DEFINITIVE PROXY STATEMENT | def14a0822_adialpharma.htm |
| 2021-08-23 | DEF 14A | 2021-09-27 | PROXY | def14a0821_adialpharm.htm |
| 2020-07-21 | DEF 14A | 2020-09-01 | DEFINITIVE PROXY STATEMENT | def14a0720_adialpharma.htm |
| 2019-07-08 | DEF 14A | 2019-08-16 | DEFINITIVE PROXY STATEMENT | def14a2019_adial.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |